Fibronectin (Fn) is a circulating and extracellular matrix glycoprotein that may serve to facilitate phagocytosis because of its ability to bind many inflammatory ligands and to a monocyte receptor. Fn fragments have been shown in many systems to have augmented properties over those of native Fn. We show in this report that although Fn fragments did not cause elastase release from monocytes in suspension, fragments did cause elastase release from monocytes that were first bound to Fn-gelatin surfaces. An amino-terminal 29-Kd and a 140-Kd integrin-binding fragment were halfmaximally active at 100 nmol/L, whereas the Arg-Gly-Asp-LASMA FIBRONECTIN (Fn) is a circulating Fn isoform P that can bind to integrin receptors on monocyte cell surfaces' and that, as an opsonin, may present various types of macromolecules to monocytes for ingestion.2 Interaction of monocytes with Fn surfaces may be an important regulator of inflammatory properties because monocyte interactions with Fn surfaces have been shown to augment the activities of the complement receptor^^.^ and the Ig Fc receptors' and to cause expression of characteristics of inflammatory macrophages, such as protease release. ' In certain diseases such as rheumatoid arthritis, enhanced Fn deposition is observed on the articular cartilage or synovial tissue This could lead to enhanced monocyte attachment to the surface and consequent monocyte activation. However, enhanced levels of fibronectin fragments (Fn-f) are also found,"." and these could interfere with either normal or pathologic Fn function. A further complication is that Fnf often have greatly enhanced or altered properties over those of native Fn,' and therefore their effect on normal Fn function cannot be predicted. Therefore, we have studied the effect of Fn-f on an important event in monocyte activity; i.e., protease release. We show here that Fn-f can cause release of elastase from Fn surface-bound monocytes, whereas native Fn cannot and actually blocks the effect of the Fn-f. Because Fn-f are found in the synovial fluid,"." the outcome could be enhanced deposition onto the cartilage or synovial tissue of elastase from tissue-bound monocytes.
MATERIALS AND METHODS
All common chemicals were of the highest quality available. Except where noted, all protease substrates, proteases, chemical reagents, and chromatography resins were from Sigma Chemical Co (St Louis, MO). Human sputum elastase and human sputum cathepsin G (41 15 U/mg) were from Elastin Products. The peptide, GRADSPK, were from ICN (Costa Mesa, CA). Bovine spleen cathepsin D; human plasma thrombin (1,300 NIH U/mg); human kidney urokinase; human plasma plasmin; human glu-plasminogen; type 1 porcine gelatin; Isolation of Fn and Fn-1: Fn was isolated from plasma by adsorption to gelatin-Sepharose and Fn-f were isolated from cathepsin D and thrombin digests of Fn as described.12 The Fn-f studied here have been and the amino-terminal sequences of some of the Fn-f p~b1ished.l~ The Fn-f from amino-terminus to carboxylterminus are a 29-Kd heparin-binding Fn-f, a 50-Kd gelatin-binding domain, a mixture of 1 IO-Kd to 150-Kd (denoted 140-Kd here) integrin-binding central Fn-f, a 35-Kd carboxyl-terminal heparinbinding Fn-f, and a mixture of 160-Kd to 190-Kd Fn-f containing the gelatin-binding and integrin-binding domains, which we term the 190-Kd Fn-f. Quantitation of Fn-f was performed by use of extinction ~0efficients.l~ Immediately before use, Fn-f solutions were dialyzed against 50 mmol/L of phosphate without protease inhibitors or against DMEM and sterile filtered. Periodic testing for endotoxin with the endotoxin kit from Sigma Chemical Co showed insignificant levels of less than 50 pg/mg protein or less than 50 pg/mL.
Isolation of human mononuclear cells and of peripheral blood monocytes und characterization. Human mononuclear cells were isolated from human buffy coats by Hypaque-Ficoll centrif~gation'~ as modified.' Viability of cells was assessed by trypan blue and was typically over 90%. Monocytes were visualized by use of the a-naphthy1 butyrate esterase kit from Sigma. Esterase staining suggested that 30% of the mononuclear cells were monocytes. Based on this determination, the preparations were diluted to 5 million monocytes per milliliter for use. To isolate purer monocytes, mononuclear cells at 10 million/mL were allowed to attach to Fn-gelatin of 35-mm culture wells and nonadherent cells washed away.' The attached monocytes were then studied for protease release without removal and reattach-FIBRONECTIN FRAGMENTS CAUSE ELASTASE RELEASE 187 ment. Such preparations were over 95% monocytes as shown by esterase staining.
Plastic 24-well tissue culture wells (1.6-cm diameter) were coated with 500 pL of a 30 mg/ mL solution of type I gelatin in PBS-Mg2+ (0.1 mol/L phosphate, 0.15 mol/L NaCI, 10 mmol/L Mg2+, pH 7.4) at 40°C. After 2 hours, the excess reagent was removed by aspiration and the well dried at 37°C for 2 hours, and 500 pL of a solution of 1 mg/mL Fn in PBSMg2+ added. After I hour at 37"C, the excess was aspirated away, washed three times with PBS-Mg2+, and the plate kept in a humidified atmosphere.
The amount of Fn bound to gelatin surfaces was determined by addition of 1Z51-labeled Fn. The amount of Fn bound was dependent on both gelatin concentration and Fn fluid phase concentrations. With our optimal conditions of 30 mg/mL gelatin and 1 mg/mL Fn, the maximal amount of Fn bound. This amount was 9 (+) 1.1 (n = 8) pg/cm2. With 5 mg/mL gelatin and I mg/mL Fn, 4.5 (+) 0.7 (n = 5) pg of Fn bound/cm'. With 30 mg/mL gelatin and 160 pg/mL Fn, 4.5 (+) 1.2 (n = 5) pg of Fn bound/cm2. The number ofmonocytes that bound were dependent on the amount of surface-bound Fn. With 9 pg of Fn/cm' and addition of 5 million monocytes in I mL, the maximal attachment was 140,000 (+) 32,000 (n = 12) monocytes/ cm', or approximately 700,000 cells/well. This represents the binding of about 14% of added monocytes.
This was performed in suspension culture in 10% fetal bovin serum-Roswell Park Memorial Institute medium (FBS-RPMI) 1640 containing 25 pg/mL gentamicin in a Corning no. 251 11 75-cm' canted neck polystyrene flask (Corning Glass Works, Corning, NY) in 5% C02-95% air at 37°C. Every 3 days, or when the cells reached a density of 1 million cells/mL, the cells were subcultured at 0.25 million cells/mL. Before the cells were used to test for elastase release, suspensions were washed three times with 50-fold dilutions of RPMI 1640 to remove serum that would inhibit released elastase. The washed cells were used within 2 hours.
These were obtained by removal of cartilage from the metacarpophalangeal joints of adult bovine animals (1 8 to 20 months old) obtained from the slaughter house. Joints were opened under aseptic conditions, slices cut from the exposed articular surface, minced with a surgical scalpel, washed with DMEM, and frozen to inactive all cellular processes.
Elastase activity was measured spectrophotometrically at 406 nm by hydrolysis of 0.5 mmol/L MANA at 22°C in a I-mL volume. Aliquots of less than 50 pL of test solution or standard and 50 pL of a 10 mmol/L solution of MANA in dimethyl sulfoxide (DMSO) were added to 50 mmol/L tris-HC1, 150 mmol/ L NaCI, pH 7.4. A 0.1 mol/L pg aliquot of human sputum elastase typically gave a rate of absorbance change at 406 nm of 0.01 U/min/ mL through a I-cm path, with 0.5 ng being the minimal amount detectable in a 30-minute assay.
Cathepsin G activity was assayed with 3 mmol/L N-succinimidyl-
mol/L NaC1, pH 7.4 at 22°C. A 0.02-pg/mL solution of human sputum cathepsin G had an absorbance change at 410 nm of0.0005/ min/mL through a I-cm light path. The minimal detectable level was 1 ng. Plasminogen activator activity was measured at 22"C, as described, by addition of test solution or 0.1 pg human urokinase to I mL of 50 mmol/L tris, 150 mmol/L NaCI, pH 7.4, containing 25 &mL Glu-plasminogen and the plasmin-substrate S-225 I . I6 The absorbance change at 406 nmol/L was monitored. The exponential rate of increase of absorbance caused by increasing plasmin activity was calculated and plotted as absorbance change versus time'. The minimal detectable activity over a 30-minute assay period corresponded to 5 ng of urokinase. 
RESULTS
Fn-fdid not cause elastase releasefrom monocytes in suspension. We first investigated the ability of Fn-f to cause elastase release from mononuclear cells. A suspension of mononuclear cells in DMEM-containing IO mmol/L of MgC12 in a sterile polypropylene tube was adjusted to 5 million monocytes/mL and l pmol/L in either native Fn, the 29-Kd, 50-Kd, 140-Kd, 35-Kd, or 190-Kd Fn-f or 1 mmol/ L in the RGDS peptide. Incubation was continued at 37°C in 95% air-5% C 0 2 . After 2 hours, 100-pL aliquots of these solutions were assayed. Such solutions were found to contain less than 0.5, 1, and 5 ng, respectively, of elastase, cathepsin G, and plasminogen activator activity per 1 million monocytes. These amounts were not considered significant. Four different mononuclear isolations gave similar results.
Fn-fdid not cause elastase release from monocytes attached to plastic. The effect of a plastic tissue culture surface on Fn fragment-mediated release was investigated next. Similar mononuclear solutions, as above, were added to each well of a 24-well tissue culture dish. After 1 hour, the density of bound monocytes was similar to that on Fn/gelatin surfaces; between 120,000 and 160,000 monocytes/cm2. The fraction of cells that attached was about 16% of applied. Fn or the Fn-fwere then added as described above. After an additional 2 hours, the incubations were assayed. None of the experimental wells showed detectable elastase, cathepsin G, or activator release when four different mononuclear preparations were assayed in this manner.
Fn-f did cause elastase release from monocytes bound to Fn-gelatin-surfaces. The effect of a Fn-gelatin surface was investigated next. Aliquots (1 mL) of similar mononuclear suspensions with 5 million monocytes per milliliter were added to each well of a 24-well tissue culture dish that had been first coated with gelatin and then with native Fn. After 1 hour, the number of monocytes bound ranged between 120,000 and 160,000 cells/cm2 or averaged 700,000 cells bound per well in a I-mL volume. Then, I-pmol/L concentrations of Fn or the Fn-f were added. After 2 hours, 100-pl aliquots of these solutions were assayed for elastase activity. In this case, the 29-Kd, 140-Kd, 190-Kd Fn-f, the Arg-GlyAsp-Ser (RGDS) peptide (Fig 1; RGD) , and a mixture of the 29-Kd, 50-Kd, 35-Kd, and 140-Kd Fn-f (MIX), respectively, caused release of 20 (+) 4, 32 (k) 5 , 35 (k) 6, 15 (+) 5, and 28 (+) 4 ng, respectively, of elastase per million monocytes (Fig 1) . The monocyte count included both bound and unbound monocytes. These data were based on seven different mononuclear isolations with two different Fn-f preparations and showed up to 17-fold stimulation of elastase release compared with bovine serum albumin (BSA) or the control that was only a gelatin surface. Incubations of cells on a Fngelatin surface with added fluid phase Fn (Fig 1: FN) caused only a slight release of elastase above control levels. Also, the RGDS mutant peptides, GRGLSLSR and GRADSPK, at 0.2 mmol/L did not cause elastase release above control levels (data not shown). Goat antibodies to human Fn, at 50 pg/ mL final concentration, decreased the 0.1 pmol/L 140-Kd Fn-f-mediated elastase release by 70 (k) 9% (n = 3).
To determine if the elastase released was presynthesized and
The elastase released was not de novo synthesized. packaged or de novo synthesized, we subjected mononuclear suspensions to lysis with 4 mol/L urea-50 mmol/L tris-150 mmol/L NaC1, pH 7.4 for 30 minutes and assayed lysates. The lysates showed 42 ng elastase/million monocytes as compared with the maximal amount of release by 1 pmol/ L 140-Kd Fn-f of 35 ng/million monocytes. Further, adjustment of cell suspensions to I O pg/mL actinomycin D for 30 minutes before Fn-f addition did not block release. Therefore, the elastase released by Fn-f was not de novo synthesized during the incubation.
Cathepsin G was also released in 140-Kd Fn-f-conditioned media at a level of 5 ng per million monocytes, about fivefold over control levels. Plasminogen activator activities could not be detected in any of the solutions.
The Fn-f were half-maximally active at 0.1 pmol/L, whereas the RGDS peptide was half-maximally active at 100 pmol/L (Fig 2) . The elastolytic activity released was not inhibited by 20 mmol/L EDTA or by 1 U/mL of the serine protease inhibitor, trasylol, but was inhibited by a 1 mmol/L concentration of the serine protease inhibitor, phenylmethylsulfonyl fluoride. A 50 U/mL final concentration of trasylol did inhibit 50% of the activity. This inhibition spectrum is similar to that found for monocytic and neutrophil elastase. For
We then investigated whether the Fn-f effect was specific and whether other components could also cause elastase release from Fn surface-bound monocytes. Concanavalin A (1 mg/mL), a monocyte activator, did not cause elastase release, although lipopolysaccharide (100 pg/mL), also an activator, caused release of 8 I% of the elastase activity of 140-Kd Fn-f treatment. Goat antirabbit IgG (50 pg/mL) did not cause release. Tissue components such as gelatin ( 1 mg/mL), heparin (50 pg/mL), and chondroitin sulfate (50 pg/mL) did not induce elastase release. However, prostaglandin E2 ( I pg/mL) caused over 80% of the release observed with the 140-Kd Fn-f. Therefore, the elastase release from Fn surface-bound cells is not specific to Fn-f.
We also tested various components for their ability to block the 1 pmol/L 140-Kd Fn-f-mediated elastase release from Fn surface-bound monocytes. The glucocorticoid dexamethasone (0.14 pmol/L) completely blocked release, whereas antibodies to Fn were less effective. However, the metabolic inhibitors deoxyglucose (3 mmol/L) and azide (0.05%) blocked elastase release by over 95% as well as did cytochalasin B (10 pg/mL). Therefore, the elastase release was energy dependent and may require microfilament structure.
To investigate how a system in which only 14% to 16% of the cells attached to Fn surfaces could release as much elastase as found in urea lysates of the same number of cells, we investigated the possible role of elastase as a soluble mediator. We found that addition of 5 ng of elastase to a 1-mL incubation of 5 million monocytes in a 1.5-mL polypropylene tube caused release of 38 (+) 19 ng (n = 7) of elastase per million monocytes within 1 hour of incubation. Because this is approximately the amount of elastase found in urea lysates of monocytes and is, therefore, the maximal amount of resident elastase that can be liberated, these results suggest that elastase released from the small fraction of Fn surface-bound monocytes also could activate suspended monocytes to release elastase.
In a second experiment, cells were added to a Fn-gelatin surface under conditions in which only a fraction of the cells could bind the surface and after 30 minutes elastase was added (5 ng/nL final). The addition of elastase caused release of 3 1 (k) 6 ng (n = 3) elastase per million monocytes within 2 hours, confirming that elastase may be a mediator of Fn-fmediated monocytic elastase release in the earlier Fn-gelatin surface experiments. A similar experiment was then performed to determine if plastic surfaces could replace the Fngelatin surfaces. Cells were first added to wells of a 24-well plastic tissue culture plate, with no Fn present, followed by addition of elastase. In this case, after 2 hours, only 2 (k) 1 ng elastase/million cells were detected, whereas controls showed undetectable levels. The elastase concentration was not significantly greater than in the control wells after 14 hours. It was expected that full elastase release would have occurred within 2 hours as with cells in the polypropylene tubes. We have no explanation for this difference. A similar experiment was then performed to test whether Fn-f would
Tests of other components.
The released elastase activated unattached monocytes.
potentiate the effect of elastase on cells bound to plastic. A solution of the 140-Kd Fn-f ( I pmol/L final) and elastase (5 ng/mL final) were simultaneously added to the cells previously added to tissue culture wells. By 2 hours, 2 ng elastase/ million cells were detected, but by 14 hours, the levels had increased to about 36 ng elastase/million cells, about fourfold over controls at that time point. Therefore, the 140-Kd Fn-f did potentiate the effect of elastase, but the overall effect occurred much more slowly than on the Fn-gelatin surface.
To determine whether elastase had to be enzymatically active to promote release of monocytic elastase, elastase test solution (0.1 mg/mL) was reacted with 0.1 mmol/L phenylmethyl sulfonyl fluoride (PMSF) and exhaustively dialyzed. The elastase derivative retained only 1% of its initial activity. This derivative (5 ng/mL final) was then added to a cell suspension on a Fn-gelatin surface, and the suspension was assayed after 2 hours. There was no increased elastase activity, even after 14 hours, suggesting that enzymatically active elastase was required for release of endogenous elastase.
Elastase release also occurred with purified monocytes and 17-937 cells. We next investigated if the elastase release from monocytes could occur in the absence of other mononuclear cells. Monocytes were purified from mononuclear suspensions by allowing the cells to adhere to Fn-gelatin surfaces. The unbound cells were washed away and Fn-f added as above to 1 pmol/L final concentrations. After a 2-hour incubation, elastase release from these bound purified monocytes was found to occur at the level of 43 (+) 4.5 ng and 27 (+) 4.3 ng of elastase release/million monocytes (n = 3 different mononuclear isolations) for the 140-Kd and 29-Kd Fn-f, respectively, whereas the other Fn-f were less than 20% as active. These cell counts were based on the number of attached cells; 14% of total applied. U-937 cells were also tested. One-milliliter suspensions from a 5 million cells/mL suspension were allowed to attach to Fn-gelatin surfaces to test for elastase release. After 1 hour, approximately 32 (k) 5% of the cells bound. The excess cells were washed away. Addition of Fn-f resulted in release of 32 (2) 4.8 ng/million (n = 5) of attached U-937 cells (data not shown).
Cartilage slices could substitute for the Fn-gelatin surface and promote elastase release. Because articular cartilage tissue has Fn bound to the surface, and because the Fn deposition can increase in rheumatoid a r t h r i t i~,~.~ we tested whether normal bovine articular cartilage would promote elastase release as did Fn-gelatin surfaces. Mononuclear suspensions were adjusted to 1 pmol/L Fn-f or Fn or 1 mmol/ L synthetic RGDS (Arg-Gly-Asp-Ser) peptide or 1 pmol/L BSA with an approximately IO-mg freeze-killed bovine articular cartilage slice. The cartilage tissue was first frozen to block any possible active responses from the tissue. Figure 3 shows the results from three different cell preparations and shows that the same Fn-f that caused elastase release from Fn-gelatin surfaces did the same in the presence of cartilage and at approximately the same levels. Native Fn, at 1 pmoll L, also blocked the Fn-f-mediated elastase release here as well, and addition of 1 mg/mL gelatin removed 72% of the blocking activity of soluble Fn. Without cartilage there was insignificant elastase release after 2 hours, and no elastolytic activity was detected in Fn-flcartilage incubations without monocytes after 2 to 6 hours.
DISCUSSION
Our objectives here were to investigate whether or not the presence of Fn-f, such as are found in arthritic synovial fluid,'0,'' and which are likely found as products of inflammation at sites oftissue injury, can modulate protease release from monocytes. We studied the effects of Fn-f both on suspended monocytes and on surface-bound monocytes because we considered that attachment may activate monocytes. A Fn surface was considered relevant for these studies because Fn may bind to sites of injury and present an attachment surface to monocytes in tissue injury. For example, in rheumatoid arthritis, enhanced levels of Fn are found on the articular cartilage surface, on the synovial membrane, and on the surface of pannus tissue near attached mononuclear cell^.^.^ To provide a Fn surface for in vitro studies, we used a Fn-gelatin surface because such a surface has been shown to promote monocyte binding in a Fn concentration-dependent fashion.' With such a surface the gelatin does not likely serve a specific function other than to concentrate the Fn to enhance the affinity for the attachment molecules/receptors.
The rationale for investigating the effect of Fn-f was because they are found in rheumatoid arthritic synovial fluids,"." in plasma after thermal injury,I8 and will likely be found in body fluids after or during any type of tissue injury in which protease activities are expressed. Because Fn-f may block normal Fn function,"." and they often have altered properties over native Fn, their activities may be of relevance in many types of pathologies. Our means of analysis of their effect was to measure certain proteases that have been shown to be released by monocytes, such as elastase,' cathepsin G,I9 and plasminogen activator.20
The Fn-f did cause elastase release but only when monocytes were first bound to a Fn-gelatin or cartilage surface. The effect of cell attachment on protease release has been reported before; for example, suspended neutrophils stimulated with soluble ligands have been reported to release very little collagenase as compared with neutrophils bound to IgGcoated surfaces or cartilage surfaces.2' Further, Wright et a1' found that soluble Fn does not activate complement receptors of monocytes but surface-bound Fn does. Also, phorbol esters have been shown to stimulate elastase and cathepsin G release from monocytes but only when Fn is surface bound.22
Many of the activities of macrophages, including chemotaxis, adherence, differentiation, secretion, and phagocytosis, can be attributed to the binding of Fn by integrin receptors on the macrophage cell surface. 
FIBRONECTIN FRAGMENTS CAUSE ELASTASE RELEASE 191
The addition of native soluble Fn may block these Fn-f effects by displacing the bound 140-Kd and 29-Kd Fn-f and allowing a readjustment of the cytoskeletal structure.
Such receptor-mediated events in mononuclear cells may require the participation of or regulation by multiple receptors. For example, a 120-Kd cell-binding Fn-f or native Fn was shown to potentiate collagen-induced secretion of interleukin-1 (IL-1) from human blood mononuclear cells by binding to the a5bl Fn i~~t e g r i n .~~ Thus, occupancy at the a,b, integrin by Fn-f or Fn apparently regulates the effects of collagen interaction at the collagen receptor, the a2bl integrin. In our system reported here, native Fn interaction appeared to potentiate the effect of Fn-f. However, we have no evidence for involvement of a collagen receptor.
The differential effect of Fn-f as compared with native Fn could be because the Fn-f may simply bind to Fn receptors differently than native Fn because of their lesser multivalent interactions at the cell surface. They may be incapable of causing receptor clustering or the normal activities of native Fn. Or they may introduce new postbinding receptor responses different than does Fn. Therefore, Fn-f may act as partial or incomplete agonists of Fn and may either activate certain processes or remove the inhibitory effects of native Fn. For example, it has been shown that when monocytes bind to Fn surfaces, complement receptor activity is enhanced, but the enhancement is removed when RGDS peptides are subsequently added.23 In this case, the RGDS peptides may block normal Fn function, whereas in our work reported here, the Fn-f may either activate or simply remove the normal blocking effect of native Fn. We found that saturation with soluble native Fn actually blocks elastase release, consistent with our suggestion that the normal effect of interaction of Fn with Fn receptors may be to disallow elastase release. The addition of Fn-f may compete with and reverse the inhibitory effect of the Fn at the basal surface.
The differential effect of native Fn and Fn-f on protease release also has been demonstrated in a neutrophil system in which Fn-f promote degranulation but native Fn does not34 and in a synovial fibroblast system in which only Fn-f promote stromelysin release. 35 We also have recently reported that Fn-f can augment metalloproteinase release from chondrocytes in cartilage, whereas native Fn does not.*'
The addition of fluid phase Fn blocked the effect of the Fn-f, suggesting that elastase release is not dependent only on the concentration of Fn-f but rather on the ratio of Fn-f to native Fn. However, addition of heparin and gelatin ligands to Fn partially removed the ability of Fn to block elastase release, likely because these ligands blocked the integrinbinding region of Fn. These observations suggest that high ratios of Fn-f and Fn-ligand complexes to Fn may favor elastase release and that Fn ligand complexes formed in vivo may not be effective in activating monocytes.
It should be noted that in our system, only about 14% of the added monocytes actually bound to the Fn surface. Because the maximal amount of elastase caused to be released by Fn-f is similar to the amount found in 4 mol/L urea lysates of the cells, the elastase must be released from suspended cells as well. Therefore, a diffusible factor(s) such as elastase may be released from bound monocytes and, in turn, augment elastase release from suspended cells. We did find that addition of elastase to suspended monocytes or to monocytes on a Fn-gelatin surface augmented elastase release. Enzymatically inactive elastase did not augment release. This general observation on the effect of elastase is similar to the observation that kallikrein stimulates release of elastase from neutrophils during c o a g~l a t i o n .~~ Also of relevance is the observation that addition of elastase or cathepsin G to monocytes has been shown to enhance release of oxygen metabolites and to enhance the oxidative metabolic re~ponse.~'
The release of elastase was blocked by deoxyglucose, sodium azide, and cytochalasin B, suggesting that metabolic energy and microfilament activity were required for the release. Actinomycin did not block, suggesting that mRNA synthesis was not required. Further, 4 mol/L urea lysates showed the same level of elastase as measured on addition of Fn-f to Fn surface-bound monocytes. Therefore, the elastase was probably packaged and secreted in an energy-dependent process when Fn-f were added. Although it is generally assumed that proteases are not packaged in cytoplasmic granules in monocytes as they are in neutrophils, it has been shown by immunoelectron microscopy that cytoplasmic granules that show peroxidase activity also contain elastase and cathepsin G activity. 38 The existence of elastase in such granules is consistent with our data presented here.
We substituted the Fn-gelatin surface with bovine articular cartilage slices that contain endogenous Fn on the surface to mimic certain events that might occur in rheumatoid arthritis. The Fn-f promoted elastase release in this system as well. Therefore, higher levels of Fn on damaged cartilage or synovial tissue may promote monocyte binding, and Fn-f in synovial fluid may promote release of elastase directly onto the tissue surface.
An interesting feature of promotion of elastase release by the Fn-f is that the proteolysis may be upregulated even further because Fn-f that indirectly cause proteolysis may originate from the induced proteolysis. This may occur in vivo because Fn-f have been shown to arise by the action of activated leukocytes on endothelial cells.39 We conclude that in conditions in which monocytes attach to Fn surfaces and in which Fn fragmentation or formation of Fn ligands is relatively high, elastase release would be greatly enhanced.
